HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: 2273020518v1 227/3/633    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Smith, J. J. Articles by Thrall, J. H. Search for Related Content PubMed PubMed Citation Articles by Smith, J. J. Articles by Thrall, J. H.

Biomarkers in Imaging: Realizing Radiology’s Future¹

¹ From the Department of Radiology and MGH Center for Biomarkers in Imaging, Massachusetts General Hospital, 15 Parkman St, WACC 515, Boston, MA 02114. Received May 6, 2002; revision requested July 10; revision received August 13; accepted October 1. Address correspondence to J.J.S. (e-mail: smith.john@mgh.harvard.edu).

Modern pharmaceuticals and medical devices have provided substantial benefits to patients throughout the world. These benefits come at a high and increasing cost, with development of the typical pharmaceutical requiring 12 years and hundreds of millions of dollars before gaining U.S. Food and Drug Administration marketing approval. Appropriate use of imaging biomarkers—defined as anatomic, physiologic, biochemical, or molecular parameters detectable with imaging methods used to establish the presence or severity of disease—offer the prospect of smaller, less expensive, and more efficient preclinical studies and clinical trials. Scientists, government regulators, and industry have all recognized the potential of biomarkers in imaging. Although real, this promise can only be realized with the rigorous application of science to their use. Success is most likely when (a) the presence of an imaging marker is closely linked with the presence of a target disease; (b) detection and/or measurement of the biomarker is accurate, reproducible, and feasible over time; and (c) measured changes are closely linked to success or failure of the therapeutic effect of the product being evaluated. By applying this paradigm to the array of imaging modalities, the radiology community is poised to become a major force in preclinical and clinical evaluations of new medical treatments.

© RSNA, 2003

Index terms: Opinions • Radiology and radiologists, research • Radiology and radiologists, socioeconomic issues

This article has been cited by other articles:

				T. A. Altes, M. Eichinger, and M. Puderbach Magnetic Resonance Imaging of the Lung in Cystic Fibrosis Proceedings of the ATS, August 1, 2007; 4(4): 321 - 327. [Abstract] [Full Text] [PDF]

				P. A. de Jong and H. A. W. M. Tiddens Cystic Fibrosis Specific Computed Tomography Scoring Proceedings of the ATS, August 1, 2007; 4(4): 338 - 342. [Abstract] [Full Text] [PDF]

				B. W. Ramsey Use of Lung Imaging Studies as Outcome Measures for Development of New Therapies in Cystic Fibrosis Proceedings of the ATS, August 1, 2007; 4(4): 359 - 363. [Abstract] [Full Text] [PDF]

				D. P. Schuster The Opportunities and Challenges of Developing Imaging Biomarkers to Study Lung Function and Disease Am. J. Respir. Crit. Care Med., August 1, 2007; 176(3): 224 - 230. [Abstract] [Full Text] [PDF]

				A. G. Sorensen Magnetic Resonance As a Cancer Imaging Biomarker J. Clin. Oncol., July 10, 2006; 24(20): 3274 - 3281. [Abstract] [Full Text] [PDF]

				T. Benner, J. J. Wisco, A. J. W. van der Kouwe, B. Fischl, M. G. Vangel, F. H. Hochberg, and A. G. Sorensen Comparison of Manual and Automatic Section Positioning of Brain MR Images Radiology, April 1, 2006; 239(1): 246 - 254. [Abstract] [Full Text] [PDF]

				A. S. Brody, H. A. W. M. Tiddens, R. G. Castile, H. O. Coxson, P. A. de Jong, J. Goldin, W. Huda, F. R. Long, M. McNitt-Gray, M. Rock, et al. Computed Tomography in the Evaluation of Cystic Fibrosis Lung Disease Am. J. Respir. Crit. Care Med., November 15, 2005; 172(10): 1246 - 1252. [Abstract] [Full Text] [PDF]

				A. S. Brody, H. Sucharew, J. D. Campbell, S. P. Millard, P. L. Molina, J. S. Klein, and J. Quan Computed Tomography Correlates with Pulmonary Exacerbations in Children with Cystic Fibrosis Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1128 - 1132. [Abstract] [Full Text] [PDF]

				J. H. Thrall Personalized Medicine Radiology, June 1, 2004; 231(3): 613 - 616. [Full Text] [PDF]

				A. S. Brody Scoring Systems for CT in Cystic Fibrosis: Who Cares? Radiology, May 1, 2004; 231(2): 296 - 298. [Full Text] [PDF]